Characterization of the polyclonal TCR repertoire in TCR-beta transgenic mice
TCR-β 转基因小鼠多克隆 TCR 库的表征
基本信息
- 批准号:7922913
- 负责人:
- 金额:$ 16.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-17 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAnatomic SitesAnatomyAnimal ModelAntigensAreaAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityBehaviorBone MarrowCD4 Positive T LymphocytesCellsCellular biologyChimera organismColitisCollaborationsColonComplexDataDatabasesEnsureEnvironmentEvaluationFoundationsFutureGenerationsGenetic ModelsGenetic Predisposition to DiseaseGoalsHomeostasisHomingImmuneImmune systemIn SituIn VitroIndividualInflammatory Bowel DiseasesIntegrinsIntestinesKnowledgeLocationMemoryMesenteryModelingMusNaturePathologyPeripheralPhenotypePhysiologicalPopulationPreparationProcessResolutionRoboticsRoleShapesSkinSpecificitySpleenT memory cellT-Cell Antigen Receptor SpecificityT-Cell DevelopmentT-Cell ReceptorT-Cell Receptors alpha-ChainT-LymphocyteTechniquesTimeTissuesTransgenic MiceUniversitiesWashingtonbasebeta Chain Antigen T Cell Receptorcostgenome sequencingin vivolymph nodesmemory CD4 T lymphocytepathogenpreventreceptorreceptor expressionresearch studystemtrafficking
项目摘要
DESCRIPTION (provided by applicant): The random generation of T cell receptor (TCR) sequences ensures a TCR repertoire capable of recognizing a wide variety of pathogens. However, study of the TCR repertoire is hampered by this great diversity. To overcome this issue, we have used a fixed TCR-beta chain model to facilitate experimental study of a polyclonal TCR repertoire. This TCR repertoire develops in a normal thymic and peripheral environment, and is subject to natural T cell selective forces, including potential interactions with self-antigens and foreign antigens from commensal flora on the skin and intestines. In previous studies, this fixed TCR-beta chain model has been useful in characterizing normal naturally arising TCR repertoires and comparing them with autoimmune repertoires. We propose here that detailed knowledge of the TCR repertoire in a fixed TCR- beta chain model will be useful for study of numerous aspects of T cell biology, Thus, the goal of this project is the complete in situ characterization of this polyclonal TCR repertoire at the individual TCR level by extensive sequencing of the variable TCR-alpha chains from T cells isolated based on spatial and phenotypic variables. One particular area of focus will be to understand the TCR specificity of naturally arising memory CD4+ T cells, which presumably arose due to encounter with self or commensal antigens, and may potentially be pathogenic. We believe these data will serve as the foundation of future studies on self-reactive regulatory and non-regulatory T cells, genetic models of autoimmune disease, memory T cells, and T cell trafficking and homeostasis.
描述(由申请人提供):随机生成的T细胞受体(TCR)序列确保了TCR谱系能够识别各种病原体。然而,这种巨大的多样性阻碍了对TCR曲目的研究。为了解决这个问题,我们使用了一个固定的TCR-β链模型来促进对多克隆TCR谱系的实验研究。这种TCR谱系在正常的胸腺和外周环境中发育,并受到自然T细胞选择性的影响,包括与皮肤和肠道共生菌的自身抗原和外来抗原的潜在相互作用。在以前的研究中,这种固定的TCR-β链模型在描述正常的自然产生的TCR谱系以及将它们与自身免疫谱系进行比较方面是有用的。我们在这里提出,在一个固定的TCR-β链模型中详细了解TCR谱系将有助于T细胞生物学的许多方面的研究,因此,本项目的目标是通过对基于空间和表型变量分离的T细胞中可变的TCR-α链进行广泛的测序,在单个TCR水平上完整地原位表征这个多克隆TCR谱系。一个特别的重点领域将是了解自然产生的记忆CD4+T细胞的TCR特异性,这些细胞可能是由于遇到自身或共生抗原而产生的,并可能是潜在的致病细胞。我们相信,这些数据将成为未来研究自我反应性调节性和非调节性T细胞、自身免疫性疾病的遗传模型、记忆性T细胞以及T细胞运输和动态平衡的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHYI S HSIEH其他文献
CHYI S HSIEH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHYI S HSIEH', 18)}}的其他基金
CAR-T cell treatment of CNS Autoimmunity
CAR-T细胞治疗中枢神经系统自身免疫
- 批准号:
10641913 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
CAR-T cell treatment of CNS Autoimmunity
CAR-T细胞治疗中枢神经系统自身免疫
- 批准号:
10539779 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
B cell-targeted CAR-T treatment of CNS Autoimmunity
B细胞靶向CAR-T治疗中枢神经系统自身免疫
- 批准号:
10514950 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
Immune interactions with commensal microbes in early life
生命早期与共生微生物的免疫相互作用
- 批准号:
10567936 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
B cell-targeted CAR-T treatment of CNS Autoimmunity
B细胞靶向CAR-T治疗中枢神经系统自身免疫
- 批准号:
10677698 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
The Role of Route of Entry by Bacterial Antigens on Colonic T Cell Responses
细菌抗原进入途径对结肠 T 细胞反应的作用
- 批准号:
9912712 - 财政年份:2018
- 资助金额:
$ 16.07万 - 项目类别:
ROLE OF STRESS IN GUT IMMUNE INTERACTIONS WITH COMMENSAL BACTERIA
压力在肠道免疫与共生细菌相互作用中的作用
- 批准号:
10204715 - 财政年份:2018
- 资助金额:
$ 16.07万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 16.07万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 16.07万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 16.07万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 16.07万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 16.07万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 16.07万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 16.07万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 16.07万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 16.07万 - 项目类别: